Effect of nadph oxidase inhibitor apocynin on the expression of hypoxia-induced factor-1a and endothelin-1 in rat carotid body exposed to chronic intermittent hypoxia

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 2, 2013, Pages 178-184

  Liu, Xue ^a   Deng, Yan ^a   Shang, Jin ^a   Yang, Xiu Hong ^a   Liu, Kui ^a   Liu, Hui Guo ^a   Xu, Yong Jian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apocynin; Chronic intermittent hypoxia; Endothelin 1; Hypoxia induced factor 1a

Indexed keywords

ACETOPHENONE DERIVATIVE; ANTIOXIDANT; APOCYNIN; ENDOTHELIN 1; HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REACTIVE OXYGEN METABOLITE;

ANIMAL; ANOXIA; ARTICLE; CAROTID BODY; DRUG ANTAGONISM; DRUG EFFECT; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ACETOPHENONES; ANIMALS; ANOXIA; ANTIOXIDANTS; CAROTID BODY; ENDOTHELIN-1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NADP; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 84902471856     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1093-z     Document Type: Article

References (42)

1. Budhiraja R, Quan SF. Sleep-disordered breathing and cardiovascular health. Curr Opin Pulm Med, 2005, 11(6): 501-506
2. Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation, 2004, 109(8):951-957
3. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-Aged adults. N Engl J Med, 1993, 328(17):1230-1235
4. Millman RP, Redline S, Carlisle CC, et al. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest, 1991, 99(4):861-866
5. Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/ diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation, 2005, 111(5):614-621
6. Jordan W, Cohrs S, Degner D, et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm, 2006, 113(2):239-254
7. Levy P, Tamisier R, Arnaud C, et al. Sleep deprivation, sleep apnea and cardiovascular diseases. Front Biosci (Elite Ed), 2012, 4(1):2007-2021
8. Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens, 1999, 17(1):61-66
9. Jordan W, Reinbacher A, Cohrs S, et al. Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin- 1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides, 2005, 26(9): 1654-1660
10. Gjorup PH, Sadauskiene L, Wessels J, et al. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens, 2007, 20(1):44-52
11. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension, 2001, 37(2 part 2 ):511-515
12. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, et al. Reactive oxygen species contribute to sleep apnea- induced hypertension in rats. Am J Physiol Heart Circ Physiol, 2007, 293(5):H2971-2976
13. Allahdadi KJ, Walker BR, Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension, 2005, 45(4):705-709
14. Lefebvre B, Godin-Ribuot D, Joyeux-Faure M, et al. Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir Physiol Neurobiol, 2006, 150(2-3):278-286
15. Yamashita K, Discher DJ, Hu J, et al. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem, 2001, 276(16):12 645-12 653
16. Kline DD, Peng YJ, Manalo DJ, et al. Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia- inducible factor 1 alpha. Proc Natl Acad Sci USA, 2002, 99(2):821-826
17. Peng YJ, Yuan G, Ramakrishnan D, et al. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol, 2006, 577(Pt 2):705-716
18. Yuan G, Nanduri J, Bhasker CR, et al. Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem, 2005, 280(6):4321-4328
19. Yuan G, Nanduri J, Khan S, et al. Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol, 2008, 217(3): 674-685
20. Semenza GL, Prabhakar NR. HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal, 2007, 9(9): 1391-1396
21. Liu HG, Liu K, Zhou YN, et al. Apocynin attenuate spatial learning deficits and oxidative responses to intermittent hypoxia. Sleep Med, 2010, 11(2):205-212
22. Liu HG, Liu K, Zhou YN, et al. Effect of NADPH oxidase activity inhibitor apocynin on blood pressure in rats exposed to chronic intermittent hypoxia and the possible mechanisms. Zhonghua Jie He He Hu Xi Za Zhi (Chinese), 2008, 31(12):921-925
23. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 2007, 87(1):245-313
24. Veasey SC, Davis CW, Fenik P, et al. Long-term inter mittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep, 2004, 27(2):194-201
25. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA, 2000, 288(16):1829-1836
26. Zamarron-Sanz C, Ricoy-Galbaldon J, Gude-Sampedro F, et al. Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch Med Res, 2006, 37(4):552-555
27. Belaidi E, Joyeux-Faure M, Ribuot C, et al. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol, 2009, 53(15):1309-1317
28. Kaehler J, Sill B, Koester R, et al. Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci (Lond), 2002, 103(Suppl 48):176S-178S
29. Sica AL, Greenberg HE, Ruggiero DA, et al. Chronicintermittent hypoxia: a model of sympathetic activation in the rat. Respir Physiol, 2000, 121(2-3):173-184
30. Greenberg HE, Sica A, Batson D, et al. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol, 1999, 86(1): 298-305
31. Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, et al. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol, 2005, 98(5):1691-1696
32. Kraiczi H, Magga J, Sun XY, et al. Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia. J Appl Physiol, 1999, 87(6):2025-2031
33. Phillips SA, Olson EB, Morgan BJ, et al. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol, 2004, 286(1):H388-393
34. Semenza GL. Regulation of oxygen homeostasis by hypoxia- inducible factor 1. Physiology (Bethesda), 2009, 24 (2):97-106
35. Narkiewicz K, van de Borne PJ, Pesek CA, et al. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation, 1999, 99(9):1183-1189
36. Peng YJ, Prabhakar NR. Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. J Appl Physiol, 2003, 94(6):2342-234937
37. Rey S, Del Rio R, Alcayaga J, et al. Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia. J Physiol, 2004, 560(Pt 2):577-586
38. Kietzmann T, Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol, 2005, 16(4-5):474-486
39. Mansfield KD, Guzy RD, Pan Y, et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-Alpha activation. Cell Metab, 2005, 1(6):393-399
40. Goyal P, Weissmann N, Grimminger F, et al. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia- inducible factor 1 via increase in reactive oxygen species. Free Radic Biol Med, 2004, 36(10):1279-1288
41. Liu HG, Wu HM, Xu YJ. Changes of blood pressure and expression of NADPH oxidase in carotid body in rats exposed to intermittent hypoxia. Zhonghua Jie He He Hu Xi Za Zhi (Chinese), 2011, 34(1):26-29
42. Moon EJ, Sonveaux P, Porporato PE, et al. NADPH oxidase- mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. Proc Natl Acad Sci USA, 2010, 107(47):20 477-20 482